OESO-SEMPIRE 17th World Conference | Esophagus 2026 | Versailles | June 14-17, 2026

Motility course

Sunday, June 14, 1:00 – 5:00 pm
Auditorium Lulli
 

Talk length and session expectations:

Session Purpose: 

  • To understand the key concepts, technologies, and performance of esophageal function testing  
  • To learn and practice the core concepts of marking, interpreting, and analyzing esophageal and reflux monitoring studies
  • To discuss the diagnosis and management of patients with reflux and motility disorders

Session Format:

  • Sessions 1 and 2: Eight questions related to esophageal motility and reflux testing will be answered. Each speaker will be given 8 minutes to speak. Each session will finish with a 12-minute panel Q&A at the end. 
  • Session 3: Case-based study interpretation and discussion led by teams of 2 presenters and 1 discussant. Each of the six cases/topics will be given 15 minutes. 

     

I. Indications and Protocols for Esophageal Function Testing

Chairs: TBD – TBD 

  1. What are the indications for esophageal manometry? – Gaurav Ghosh (USA)
  2. What are the equipment options and protocols used for esophageal manometry? – Irene Sonu (USA)
  3. What are the indications for ambulatory reflux monitoring? – TBD
  4. What are the equipment options and protocols used for objective reflux testing? – Sravanya Gavini (USA)
  5. What are the indications for FLIP? – Marc Wong (Hong Kong, China)
  6. What are the equipment options and protocols used for FLIP? – Priya Kathpalia (USA)

Panel Chat/Q&A
​

II. Metrics and Interpretation of Motility and Reflux Testing

Chairs: TBD  – TBD

  1. High-resolution manometry (HRM) metrics for esophageal motility interpretation – Paul Menard Katcher (USA)
  2. Interpretation of HRM – Chicago classification and special considerations – Diana Snyder (USA)
  3. What are the metrics used for ambulatory reflux monitoring interpretation? – Yan Jiang (USA)
  4. Interpretation of ambulatory reflux testing – Lyon consensus and special considerations – Marco Sozzi (Italy)
  5. What are the protocols and metrics used for FLIP interpretation?  – Allyson Richardson (USA)
  6. Interpretation of FLIP – Dallas consensus and special considerations – Anh Nguyen (USA)

Panel Chat/Q&A

 

III. Esophageal Function Testing Interpretation Workshop 

Chairs: TBD – TBD 

(6 cases presented; speaker will be given the following cases to prepare using images provided from Laborie equipment, presented in CPC fashion with audience participation)

  1. Achalasia spectrum disorder. 
    Presenters: Marc Wong (Hong Kong) and Allyson Richardson; Discussant: Renato Salvador (Italy)
     
  2. Disorder of peristalsis: hypermotility disorder.
    Presenters: Diana Snyder (USA) and Paul Menard Katcher; Discussant: Ellen Stein (USA)
     
  3. Disorder of peristalsis: hypomotility disorder.
    Presenters: Irene Sonu (USA) and Priya Kathpalia (USA); Discussant: José María Remes Troche (Mexico)
     
  4. Gastroesophageal reflux disease: unproven GERD: focusing on wireless pH monitoring.
    Presenters: Yan Jiang (USA) and Gaurav Ghosh (USA); Discussant: Roger Tatum (USA)
     
  5. Gastroesophageal reflux disease: proven GERD: focusing on pH-impedance monitoring.
    Presenters: Sravanya Gavini (USA) and Marco Sozzi (USA); Discussant: Walter W. Chan (USA)
     
  6. Behavioral syndrome (SGB plus rumination) focusing on pH impedance off therapy.
    Presenters: Akinari Sawada (Japan) and Benjamin Rogers (USA); Discussant: C. Prakash Gyawali (USA)